brusatol has been researched along with bruceantin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinghorn, AD; Ren, Y | 1 |
| Chaney, SG; Considine, RT; Hall, IH; Lee, KH; Willingham, W | 1 |
| Hall, IH; Ibuka, T; Imakura, Y; Lee, KH; Liou, YF; Okano, M; Sims, D | 1 |
| Fukamiya, N; Lee, KH; Ohno, N; Okano, M; Tagahara, K | 1 |
| Daeuble, JF; Dou, J; Grieco, PA; Kinghorn, AD; Mata-Greenwood, E; McChesney, JD; Mehta, RG; Pezzuto, JM | 1 |
5 other study(ies) available for brusatol and bruceantin
| Article | Year |
|---|---|
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Diterpenes; Humans; Neoplasms; Sesquiterpenes; Structure-Activity Relationship; Triterpenes | 2020 |
Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte system.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Proteins; Glaucarubin; In Vitro Techniques; Phenanthrenes; Protein Biosynthesis; Quassins; Rabbits; Reticulocytes | 1984 |
Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; DNA, Neoplasm; Glaucarubin; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasm Proteins; Phenanthrenes; Quassins; Sesquiterpenes; Sesquiterpenes, Guaiane; Thymidine | 1981 |
Synthesis of cytotoxic fluorinated quassinoids.
Topics: Acylation; Antineoplastic Agents, Phytogenic; Fluorine; Glaucarubin; Humans; Models, Chemical; Quassins; Tumor Cells, Cultured | 1997 |
Novel esters of glaucarubolone as inducers of terminal differentiation of promyelocytic HL-60 cells and inhibitors of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesion formation in mouse mammary organ culture.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Differentiation; Cell Division; Cell Membrane; DNA; Drug Screening Assays, Antitumor; Female; Glaucarubin; Glycosylation; HL-60 Cells; Humans; Inhibitory Concentration 50; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Models, Biological; Molecular Structure; Nitroblue Tetrazolium; Organ Culture Techniques; Plants, Medicinal; Quassins; Rats; Simaroubaceae; Structure-Activity Relationship; Time Factors; Tumor Cells, Cultured | 2001 |